INTRODUCTION
Mucins are high molecular weight glycoproteins that contain a central polypeptide (apomucin) with numerous attached carbohydrate chains. Their functions are to form a mucous gel covering the surfaces of epithelial tissues in order to lubricate and protect them (1) (2) (3) (4) (5) (6) (7) (8) . Their genes are clustered on chromosome 11p15.5 (4) . In recent studies, 20 different human mucin genes coding apomucins have been identified (MUC 1, 2, 3A, 3B, 4, 5AC, 5B, 6, 7, 8, 9, 11, 12, 13, 15, 16, 17, 18, 19, 20) (1, 9, 10).
MUC1 (episialin) is a membrane-bound mucin, which is expressed in many epithelial tissues like the breast, pancreas, and gastrointestinal, respiratory and urinary systems. It is widely expressed especially in the lactational breast. In addition, it is accepted as a normal gastric mucin, cytoplasmic and luminally expressed in foveolar cells in the stomach, and chief and parietal cells in corpus glands. MUC1 expression rates were studied in gastric, colonic and pancreatic adenocarcinomas and in breast carcinomas in many researches (1-3, 5-7, 11-20) .
MUC2 is the main mucin of the intestinal mucosa and respiratory system, and does not show any staining in normal gastric epithelium; however, de novo expressions appear in the areas of intestinal metaplasia (IM) and in malignancies (1) (2) (3) (4) (5) (6) (7) (8) (13) (14) (15) (16) (17) (18) (19) (20) . The expression of MUC2 is very common in mucinous carcinomas of different organs such as breast, colon and prostate (21) (22) (23) .
MUC5AC, a gastric-type mucin of the cardia and corpus of the stomach, is widely expressed in normal gastric epithelium (3, 4, (6) (7) (8) (13) (14) (15) (16) (17) (18) (19) (20) .
Mucin profiles of tissues, such as synthesis and glycosylation rates, show many changes in carcinomas. These changes, playing a great role in cellular growth and adhesion and also in immune system regulation, affect the invasion and metastatic capacity of the tumor. In many studies, decreases in the expression rates of MUC1 and MUC5AC and de novo MUC2 expression in gastric carcinomas have been shown to be correlated with the prognosis (1) (2) (3) (4) (5) (6) (7) (8) (13) (14) (15) (16) (17) (18) (19) (20) .
In this study, we investigated MUC1, MUC2 and MUC5AC expressions and their relations with the clinicopathological characteristics in a large series of gastric carcinomas composed of 257 patients, in order to compile additional information about the prognostic factors in gastric carcinomas.
MATERIALS AND METHODS

Patients
Gastrectomy specimens of 257 patients (201 males, 56 females) with gastric carcinomas diagnosed in the Pathology Department of the Ministry of Health Ankara D›flkap› Training and Research Hospital between January 2000 and December 2007 were selected for this study. None of the patients received preoperative chemotherapy or radiation therapy. The data on the age of the patients, tumor location and distant metastasis were obtained by reviewing clinical charts and pathological records. Hematoxylin-eosin slides of the cases were evaluated by two pathologists retrospectively. Histological classifications, according to the World Health Organization (WHO) (24) and Lauren (25) and macroscopic classification, according to the Borrmann's classification (26) , were done. In addition, differentiation of adenocarcinoma and IM in nontumoral epithelium, invasion depth of tumor (pT), lymph node metastasis (pN), perinodal invasion in metastatic lymph nodes, and perineural and angiovascular invasions were evaluated separately for each case. Tumor staging was done using Tumor Node Metastasis (TNM) system according to the American Joint Committee on Cancer (AJCC) (27) . The clinicopathological parameters evaluated are shown in Table 1 .
Immunohistochemistry
Hematoxylin-eosin slides of all the tumor tissues were evaluated, and for each case, the best paraffin block, having the least necrosis and hemorrhage and the highest tumor content, was chosen in order to prevent artefact staining. These formalinfixed, paraffin-embedded blocks were sliced in 2.5 μm thicknesses, deparaffinized and rehydrated. Microwave pre-treatment using 0.01M sodium citrate buffer was only employed to the slides of MUC5AC. All the slides were incubated with 3% hydrogen-peroxide in phosphate buffered saline (PBS) for 20 minutes (min) at room temperature in order to block endogenous peroxidase activity. Immunoperoxidase staining was performed using the streptavidin-biotin peroxidase method. The tissue sections of each case were incubated with MUC1 (Neomarkers, RB-9222-P, 1:100), MUC2 (Neomarkers, MS-1037-P, 1:100) and MUC5AC (Neomarkers, MS-145-P, 1:100) primary antibodies at room temperature for 1 hour (h). 3-amino-9-ethylcarbazole (AEC) was used as the chromogene and hematoxylin as the counterstain. The positive controls were breast carcinoma tissue for MUC1, normal colonic mucosa for MUC2 and normal gastric mucosa for MUC5AC. PBS was used instead of primary antibody as negative control.
The 'expression rate', the extent of staining for each MUC, was scored according to the number of cytoplasmic and luminal stained carcinoma cells in 100 tumor cells. Less than 5% positive cells was accepted as negative, while ≥5% positive cells was accepted as positive. 
Statistical Analysis
Statistical analysis was performed using chi-square and Fisher's exact tests. P values less than 0.05 were considered to be statistically significant.
RESULTS
MUC1 Expression
MUC1 showed strong cytoplasmic and luminal expression in normal gastric epithelium. The correlations between MUC1 expression rate and the clinicopathological parameters that were statistically significant are shown in Table 2 . The expression rate decreased with the loss of tumor differentiation. The staining was positive in 92.6% of well differentiated tumors (Figure 1 ), but only positive in 83.7% of poorly differentiated tumors. The expression rate was 98.4% in the cases with no metastatic lymph nodes; however, it decreased in metastatic pN3 cases (67.9%). Distant metastatic cases showed a tendency to lose the expression (the 
MUC2 Expression
There was no MUC2 expression in normal gastric epithelium; however, de novo expressions appeared in tumoral tissues as shown in was 94.7%, while it was 70.7% in stage 4 cases. There was no statistically significant relation with the rest of the clinicopathologic parameters (p>0.05) ( Table 1 ). All of the tumors with IM showed MUC2 expression; however, this was not statistically significant (p>0.05).
MUC5AC Expression
MUC5AC was strongly expressed in normal gastric epithelium. The correlation between MUC5AC expression rate and the clinicopathological parameters is shown in Table 4 . According to Lauren's classification, intestinal-type carcinomas showed higher (48.4%) expression rate than the diffusetype (10%). Most of the mucinous (90.5%) and signet ring cell (89.4%) carcinomas were MUC5AC-negative ( Figure 4 ). The expression rate in well differentiated tumors was 92.6%, while it was 13% in poorly differentiated tumors. There was no loss of MUC5AC expression in pT1 tumors, but 66.7% of the pT4 tumors were negative. This correlation was true also with the metastatic lymph node stage, with the negativity rates of 39.7% in pN0 cases and 89.3% in pN4 cases. According to the TNM stage, stage 4 cases showed higher (82.9%) loss of MUC5AC expression than stage 1 cases (31.6%). The lowest expression rate was in the diffuse type according to the Borrmann's classification. There was no statistically significant correlation with the rest of the parameters (p>0.05) ( Table 1) .
DISCUSSION
Gastric carcinoma is one of the most frequent carcinomas. Although the incidence rate has shown a declining trend in recent years, the mortality is still quite high (28, 29) . The prognosis of gastric carcinoma depends mostly on the histopathological grade and the stage. However, they are not al- Table 3 . Correlation between MUC2 expression rates and the clinicopathological parameters that are statistically significant ways enough to predict the probability of relapse, metastasis and the overall survival (29, 30) . Therefore, new prognostic factors are needed and have been detected in many researches, like mucin profiles of the tumors (1-23).
In this study, the correlation between MUC1, MUC2 and MUC5AC expression rates and the clinicopathological features were analyzed in a series of 257 gastric carcinomas. We demonstrated that MUC1, which is a gastric mucin, showed higher expression rates in intestinal type adenocarcinomas, especially in well-and moderately differentiated types, in agreement with Akyürek et al.
(2) and Barresi et al. (1) . The higher expression of MUC1 in well differentiated adenocarcinomas is meaningful in showing gastric differentiation, since MUC1 is a main mucin of normal gastric mucosa. In addition, we found that loss of MUC1 expression rate increased with the progress in metastatic lymph node stage (pN), distant metastasis and the TNM stage. All of the TNM stage 1 cases were MUC1-positive, while only 75.6% of the stage 4 cases showed positivity. These results may suggest that the deviation in the normal mucin content of gastric mucosa composed of MUC1 is related with the poorer differentiation, increased metastatic capacity and advanced stage (2, 5).
MUC2 was not expressed in normal gastric mucosa as it is an intestinal type mucin. (4) demonstrated that there was no significant difference between intestinal and diffuse types of carcinomas and between well/moderately differentiated carcinomas and poorly/undifferentiated carcinomas. They also declared that there was no relation with the pT, pN and TNM stages of the cases (4). In addition, in our study, the expression rate of MUC5AC decreased with the loss of tumor differentiation, with the increase in tumor invasion depth and the number of metastatic lymph nodes, and consequently, with the progress in TNM stage. Moreover, the expression rate decreased significantly with the progress in macroscopic Borrmann's classification. The lowest expression rate was seen in diffuse macroscopic type, which has the worst prognosis. These results suggest that MUC5AC, which is a gastric mucin, loses its expression in progressive cases (3). Thus, it can be suggested that the expression of MUC5AC in gastric carcinoma may be a good indicator for prognosis.
In conclusion, mucin expression in gastric carcinoma is fairly complex. However, we conclude that MUC1 and MUC5AC expression rates might be good prognostic parameters in gastric carcinoma, and MUC2 might be a good marker for mucinous carcinoma. When each of these three markers is evaluated in the light of clinical and pathological parameters, all of them may be useful as significant prognostic parameters in showing the progression of the tumors.
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